PubMed İndeksli Yayınlar Koleksiyonu
Permanent URI for this collectionhttps://hdl.handle.net/11727/4810
Browse
4 results
Search Results
Item Epidemiologic features of inflammatory bowel disease in Western Blacksea region of Turkey for the last 10 years: retrospective cohort study(2019) Can, Guray; Posul, Emrah; Yilmaz, Bulent; Can, Hatice; Korkmaz, Ugur; Ermis, Fatih; Kurt, Mevlut; Dagli, Ulku; 29695147Background/Aims: There are only a few epidemiological study about inflammatory bowel disease in the last 10 years in Turkey, especially in Western Blacksea region. In our study, we aimed to identify the changes in the incidence and the prevalence of inflammatory bowel disease in Western Blacksea region at the last 10 years. Methods: Totally 223 patients with inflammatory bowel disease (160 ulcerative colitis, 63 Crohn's disease) were enrolled in the study followed up between 2004 to 2013 years. The epidemiological characteristics of patients were recorded. Results: The prevalences were 12.53/10(5) and 31.83/10(5) for Crohn's disease and ulcerative colitis respectively. Mean annual incidences increased from 0.99/10(5) and 0.45/10(5) for ulcerative colitis and Crohn's disease (2004 to 2005 years) to 4.87/10(5) and 2.09/10(5) for ulcerative colitis and Crohn's disease respectively (2011 to 2013 years). While the prevalence was higher in urban areas in Crohn's disease (12.60/10(5)), it was higher in rural areas in ulcerative colitis (36.17/10(5)). In ulcerative colitis, mean annual incidences were 2.91/10(5) and 2.86/10(5) for urban and rural areas respectively. In Crohn's disease, they were 1.37/10(5) and 1.08/10(5) for urban and rural areas respectively. Conclusions: The incidence of inflammatory bowel disease seems to increase in Western Blacksea region at the last 10 years. This increment is more prevalent in rural areas.Item 2019 Expert opinion on biological treatment use in inflammatory bowel disease management(2019) Toruner, Murat; Akpinar, Hale; Akyuz, Filiz; Dagli, Ulku; Hamzaoglu, Hulya Over; Tezel, Ahmet; Unsal, Belkis; Yildirim, Suleyman; Celik, Aykut Ferhat; 32207688Item The role of lifestyle changes in gastroesophageal reflux diseases treatment(2017) Dagli, Ulku; Kalkan, Ismail Hakki; 0000-0003-0664-0976; 29199165; S-4068-2018Lifestyle modification has an important role in the treatment of gastroesophageal reflux disease (GERD). The development of GERD symptoms with various foods shows individual differences. Although there is not enough evidence that certain substances in a diet could lead to GERD symptoms, the literature suggests that there might be a relationship between reflux development and salt, salted foods, chocolate, fatty foods, and fizzy drinks. Because lying on the left side and raising the head of the bed in a supine position reduces the development of nocturnal reflux symptoms, the head should be elevated for patients with reflux symptoms at night, and the patient should lie on the left side. Smoking and obesity (especially abdominal) trigger GERD symptoms. Whereas excessive physical activity is a significant risk factor for the development of GERD, regular and mild-moderate physical activity has been shown to reduce the symptoms of reflux.Item Treatment of reflux disease during pregnancy and lactation(2017) Dagli, Ulku; Kalkan, Ismail Hakki; 0000-0003-0664-0976; 29199169; S-4068-2018Gastroesophageal reflux disease (GERD) is frequently seen during pregnancy. In the medical treatment of pregnant women with GERD, alginic acid and sucralfate can be used. Calcium- and magnesium-based antacids can also be used, particularly for patients with preeclampsia. In particular, ranitidine -a histamine-2 receptor blocker-is preferred. In the case of non-responsiveness to the abovementioned treatments, proton pump inhibitors (PPIs), except omeprazole, can be given considering the benefit-harm ratio for the mother and fetus after the first trimester. In cases with GERD during the lactation period, drugs having minimum systemic absorption, such as sucralfate and alginic acid, are preferable but there is no data.